From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

Emerging as the leader in ultra-rare diseases treatments, Alexion has been a huge success story, bringing breakthroughs to disabling and fatal conditions. But this success brings pressure from ...

(Pharmalot) Reference links: FDA news release. ClaireMorris. 22 April, 2013. Bookmark this. Editor's Picks. Gilead's twice-yearly PrEP drug is cleared by FDA .